Chief Minister Mohan Charan Majhi on Tuesday announced that Odisha is poised to become a top destination for pharmaceutical and medical device investments, emphasizing the State’s potential as a hub ...

Mutual funds net buyers; HDFC Bank, ICICI Bank lead inflowsBharti Airtel, Infosys, TCS among top stocks boughtSelling seen in ...

Ozempic has been widely discussed internationally for its use among celebrities and its impact on weight loss; however, the ...

The transaction accelerates the expiration of biosimilars non-compete restrictions, the company said.

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

Mumbai, Delhi and Bengaluru alone account for one-third of GLP-1 sales. Analysts cite affordability, accessibility and ...

Overview Sensex and Nifty rose only marginally, whereas sectoral indices, particularly metals, autos, and power, staged a strong outperformance.Major events suc ...

Yurpeak is the second tirzepatide brand from Eli Lilly to be launched in the country after receiving approval from the drug regulator.

Commenting on the launch, Achin Gupta, Global Chief Operating Officer, Cipla Limited, said, "The launch of Yurpeak marks a transformative moment in the fight against obesity and type 2diabetes ...

Even as global sentiment strengthened overnight after the US Fed delivered a 25-bps rate cut to 3.50%-3.75%, the GIFT Nifty ...